The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 29, 2021

Filed:

Dec. 19, 2018
Applicant:

Aziyo Med, Llc, Silver Spring, MD (US);

Inventor:

Robert G. Matheny, Norcross, GA (US);

Assignee:

AZIYO MED, LLC, Silver Spring, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61K 35/12 (2015.01); A61K 35/37 (2015.01); A61L 33/00 (2006.01); C07H 15/00 (2006.01); A61L 27/36 (2006.01); A61L 31/00 (2006.01); A61L 27/38 (2006.01); A61L 27/34 (2006.01); A61N 1/375 (2006.01); A61F 2/02 (2006.01); A61L 27/54 (2006.01); A61L 31/16 (2006.01); A61L 27/50 (2006.01); A61L 31/14 (2006.01); A61L 27/22 (2006.01); A61L 31/04 (2006.01); A61K 35/38 (2015.01); A61K 35/22 (2015.01); A61F 2/24 (2006.01); A61K 38/00 (2006.01); A61K 35/42 (2015.01); A61K 38/18 (2006.01);
U.S. Cl.
CPC ...
A61L 27/3629 (2013.01); A61F 2/0077 (2013.01); A61F 2/02 (2013.01); A61L 27/227 (2013.01); A61L 27/34 (2013.01); A61L 27/362 (2013.01); A61L 27/3604 (2013.01); A61L 27/3625 (2013.01); A61L 27/3633 (2013.01); A61L 27/38 (2013.01); A61L 27/3804 (2013.01); A61L 27/3834 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 31/005 (2013.01); A61L 31/041 (2013.01); A61L 31/14 (2013.01); A61L 31/16 (2013.01); A61N 1/375 (2013.01); A61N 1/3752 (2013.01); A61N 1/37512 (2017.08); A61F 2/24 (2013.01); A61F 2002/0086 (2013.01); A61F 2210/0076 (2013.01); A61K 35/12 (2013.01); A61K 35/22 (2013.01); A61K 35/37 (2013.01); A61K 35/38 (2013.01); A61K 35/42 (2013.01); A61K 38/005 (2013.01); A61K 38/1825 (2013.01); A61L 27/3679 (2013.01); A61L 27/3683 (2013.01); A61L 2300/20 (2013.01); A61L 2300/23 (2013.01); A61L 2300/25 (2013.01); A61L 2300/252 (2013.01); A61L 2300/40 (2013.01); A61L 2300/404 (2013.01); A61L 2300/406 (2013.01); A61L 2300/41 (2013.01); A61L 2300/412 (2013.01); A61L 2300/414 (2013.01); A61L 2300/418 (2013.01); A61L 2300/434 (2013.01); A61L 2300/45 (2013.01); A61L 2300/64 (2013.01); A61L 2400/02 (2013.01); A61L 2400/12 (2013.01); A61L 2400/18 (2013.01); A61L 2430/20 (2013.01);
Abstract

An implantable medical product and method of use for substantially reducing or eliminating harsh biological responses associated with conventionally implanted medical devices, including inflammation, infection and thrombogenesis, when implanted in in a body of a warm blooded mammal. The bioremodelable pouch structure is configured and sized to receive, encase and retain an electrical medical device therein and to allow such device to be inserted into the internal region or cavity of the pouch structure; with the pouch structure formed from either: (a) first and second sheets, or (b) a single sheet having first and second sheet portions. After receiving the electrical device, the edges around the opening are closed by suturing or stapling. The medical device encased by the bioremodelable pouch structure effectively improves biological functions by promoting tissue regeneration, modulated healing of adjacent tissue or growth of new tissue when implanted in the body of the mammal.


Find Patent Forward Citations

Loading…